2020
DOI: 10.1016/j.rbmo.2020.08.031
|View full text |Cite
|
Sign up to set email alerts
|

Preimplantation genetic testing as a component of root cause analysis of errors and reassignment of embryos in IVF

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…The current methods and quality control protocols in clinical laboratories fall short of fully tracking samples throughout the testing process [ 29 ]. Although the establishment of medical testing centers and adoption of new equipment have been effective in reducing the number of manual errors, challenges persist, particularly in the pretest phase [ 15 , 30 ]. For example, in the case of WES samples obtained from prenatal fetal sources (such as villi, amniotic fluid, and umbilical cord blood) or from miscarriage tissues, it is only after processing the sequencing data that one can determine whether the sample is singular or mixed.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The current methods and quality control protocols in clinical laboratories fall short of fully tracking samples throughout the testing process [ 29 ]. Although the establishment of medical testing centers and adoption of new equipment have been effective in reducing the number of manual errors, challenges persist, particularly in the pretest phase [ 15 , 30 ]. For example, in the case of WES samples obtained from prenatal fetal sources (such as villi, amniotic fluid, and umbilical cord blood) or from miscarriage tissues, it is only after processing the sequencing data that one can determine whether the sample is singular or mixed.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the application of fully automated equipment and information systems, that streamline manual operations, the potential for technical error persists. Addressing issues such as sample exchange, contamination, and label loss or damage remains a challenge [ 15 ]. Even when quality control materials involve exogenous DNA sequences, they only allow quality control during the post-DNA extraction detection steps [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation